Skip to main
ALHC
ALHC logo

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare (ALHC) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 50%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Alignment Healthcare Inc. is positioned to capitalize on a favorable 2026 Medicare Advantage (MA) rate update, particularly as many managed care organizations (MCOs) are reducing benefits, giving ALHC a competitive advantage through its Stars funding. The company's integrated MA-Value-Based Care (VBC) model is anticipated to support long-term market share gains and foster above-average growth. Additionally, the projected gross profit per member per month (PMPM) for early cohorts is expected to increase significantly over time, with estimates ranging from $90-$150 initially, potentially reaching over $230 PMPM by years 3-5, indicating a robust financial trajectory.

Bears say

Alignment Healthcare has demonstrated a notable ability to reduce Average Daily Census (ADK) during a period characterized by increased healthcare utilization, suggesting underlying operational strengths; however, this does not fully mitigate potential concerns. Despite achieving above-average EBITDA growth and a valuation multiple that is somewhat elevated compared to peer Medicare Managed Care Organizations (MCOs), persistent challenges related to data friction among payors and inconsistency in results from affiliated primary care providers signal operational vulnerabilities. Consequently, the underlying issues present in its value-based care (VBC) model may undermine the long-term financial stability of Alignment Healthcare, contributing to a negative outlook on the stock.

Alignment Healthcare (ALHC) has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 50% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alignment Healthcare (ALHC) Forecast

Analysts have given Alignment Healthcare (ALHC) a Buy based on their latest research and market trends.

According to 10 analysts, Alignment Healthcare (ALHC) has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.95, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.95, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alignment Healthcare (ALHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.